Your browser doesn't support javascript.
loading
Characteristics and Outcomes for Recipients of NVX-CoV2373: A Real-World Retrospective Study in Germany.
Kutikova, Lucie; Brash, James T; Helme, Kawitha; Brewster, Jack; Brand, Milou; Adam, Atif; Seager, Sarah; Kostev, Karel; Schelling, Jörg.
Affiliation
  • Kutikova L; Novavax Europe, 8001 Zurich, Switzerland.
  • Brash JT; IQVIA, London W2 1AF, UK.
  • Helme K; Novavax Europe, 8001 Zurich, Switzerland.
  • Brewster J; IQVIA, London W2 1AF, UK.
  • Brand M; IQVIA, London W2 1AF, UK.
  • Adam A; IQVIA, London W2 1AF, UK.
  • Seager S; IQVIA, London W2 1AF, UK.
  • Kostev K; IQVIA, Epidemiology, 60549 Frankfurt am Main, Germany.
  • Schelling J; Department of Medicine IV, Ludwig Maximilian University of Munich University Hospital, LMU Munich, 80336 Munich, Germany.
Vaccines (Basel) ; 12(4)2024 Apr 06.
Article in En | MEDLINE | ID: mdl-38675769
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2024 Document type: Article Affiliation country: Suiza Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2024 Document type: Article Affiliation country: Suiza Country of publication: Suiza